BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
32990384
Number of visits today
4739
Number of downloads
16170351
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Cheal SM, Chung SK, Vaughn BA, Cheung NV, Larson SM. Pretargeting: A Path Forward for Radioimmunotherapy. J Nucl Med 2022;63:1302-15. [DOI: 10.2967/jnumed.121.262186] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Aboagye EO, Barwick TD, Haberkorn U. Radiotheranostics in oncology: Making precision medicine possible. CA Cancer J Clin 2023. [PMID: 36622841 DOI: 10.3322/caac.21768] [Reference Citation Analysis]
2 Albertsson P, Bäck T, Bergmark K, Hallqvist A, Johansson M, Aneheim E, Lindegren S, Timperanza C, Smerud K, Palm S. Astatine-211 based radionuclide therapy: Current clinical trial landscape. Front Med (Lausanne) 2022;9:1076210. [PMID: 36687417 DOI: 10.3389/fmed.2022.1076210] [Reference Citation Analysis]
3 Lugat A, Bailly C, Chérel M, Rousseau C, Kraeber-Bodéré F, Bodet-Milin C, Bourgeois M. Immuno-PET: Design options and clinical proof-of-concept. Front Med (Lausanne) 2022;9:1026083. [PMID: 36314010 DOI: 10.3389/fmed.2022.1026083] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345